Carregant...
Rituximab, MS, and pregnancy
OBJECTIVE: To describe the safety and efficacy of rituximab (RTX) in MS and pregnancy, we conducted a retrospective cohort study of 74 pregnancies among 55 women treated with RTX for MS and their offspring. METHODS: We used prospectively collected information from the electronic health record at Kai...
Guardat en:
| Publicat a: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217660/ https://ncbi.nlm.nih.gov/pubmed/32358226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000734 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|